201600930 ( DrugBank: - )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
2筋萎縮性側索硬化症1

2. 筋萎縮性側索硬化症


臨床試験数 : 624 薬物数 : 611 - (DrugBank : 160) / 標的遺伝子数 : 172 - 標的パスウェイ数 : 225
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2020-005018-17-NL
(EUCTR)
14/05/202108/04/2021Safety and tolerability of Trimetazidine in amyotrophic lateral sclerosis (ALS)Targeting metabolic flexibility in ALS (MetFlex); Safety and tolerability of Trimetazidine for the treatment of ALS - MetFlex Patients suffering from amyotrophic lateral sclerosis (ALS);Therapeutic area: Diseases [C] - Nervous System Diseases [C10]Trade Name: Vastarel
Product Name: Trimetazidine
Product Code: 201600930
The University of QueenslandNULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes
36Phase 2Australia;Netherlands